| Style | Citing Format |
|---|---|
| MLA | Shayanmanesh M, et al.. "Expression Patterns of Gpx4 and Linc00618 Across Disease Phases in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia (Bcp-All): An Exploratory Study." BMC Cancer, vol. 26, no. 1, 2026, pp. -. |
| APA | Shayanmanesh M, Ahmadi S E, Faranoush M, Safa M, Nourbakhsh S M K, Jaafarian A S, Amini A (2026). Expression Patterns of Gpx4 and Linc00618 Across Disease Phases in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia (Bcp-All): An Exploratory Study. BMC Cancer, 26(1), -. |
| Chicago | Shayanmanesh M, Ahmadi S E, Faranoush M, Safa M, Nourbakhsh S M K, Jaafarian A S, Amini A. "Expression Patterns of Gpx4 and Linc00618 Across Disease Phases in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia (Bcp-All): An Exploratory Study." BMC Cancer 26, no. 1 (2026): -. |
| Harvard | Shayanmanesh M et al. (2026) 'Expression Patterns of Gpx4 and Linc00618 Across Disease Phases in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia (Bcp-All): An Exploratory Study', BMC Cancer, 26(1), pp. -. |
| Vancouver | Shayanmanesh M, Ahmadi S E, Faranoush M, Safa M, Nourbakhsh S M K, Jaafarian A S, et al.. Expression Patterns of Gpx4 and Linc00618 Across Disease Phases in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia (Bcp-All): An Exploratory Study. BMC Cancer. 2026;26(1):-. |
| BibTex | @article{ author = {Shayanmanesh M and Ahmadi S E and Faranoush M and Safa M and Nourbakhsh S M K and Jaafarian A S and Amini A}, title = {Expression Patterns of Gpx4 and Linc00618 Across Disease Phases in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia (Bcp-All): An Exploratory Study}, journal = {BMC Cancer}, volume = {26}, number = {1}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Shayanmanesh M AU - Ahmadi S E AU - Faranoush M AU - Safa M AU - Nourbakhsh S M K AU - Jaafarian A S AU - Amini A TI - Expression Patterns of Gpx4 and Linc00618 Across Disease Phases in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia (Bcp-All): An Exploratory Study JO - BMC Cancer VL - 26 IS - 1 SP - EP - PY - 2026 ER - |